Approval for a drug containing cannabis in France…The French Agency for the Safety of Medicines and Healthcare Products (ANSM) gave the green light for a drug called Sativex, which contains Marijuana (Cannabis). The drug, which has caused controversy in France due to its content, will be launched soon.
(Multiple Sclerosis) The presence of cannabis in the content of Sativex, which is used in the treatment of MS disease, was not welcomed by some parts of the country. Marijuana is a naturally grown type of drug that has been proven to be addictive. The legalization of the use of such drugs in the pharmaceutical industry in Europe is still a matter of debate. (Multiple Sclerosis) Sativex, which is used in the treatment of MS disease, has been on the market for a long time in England and Germany.
Source : euronews